Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Mesters

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Der Internist|December 28, 1999
[Therapy of deep venous thrombosis]R M Mesters
Annals of Hematology|March 4, 2003
Angiogenesis in hematologic malignanciesR M Mesters
Der Internist|September 15, 2000
[Oral anticoagulation versus low-molecular heparin (LMWH)]R M Mesters
Der Internist|January 1, 1995
[Hemorrhagic diathesis]R M Mesters, W Stenzinger
The Journal of Biological Chemistry|December 25, 1991
Identification of a sequence of human activated protein C (residues 390-404) essential for its anticoagulant activityR M Mesters, R A Houghten, J H Griffin
Biochemistry|November 30, 1993
A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor VaR M Mesters, M J Heeb, J H Griffin
Thrombosis and Haemostasis|June 1, 1996
Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsisR M Mesters, N Flörke, H Ostermann, et al.
Protein Science : a Publication of the Protein Society|September 1, 1993
Interactions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein CR M Mesters, M J Heeb, J H Griffin
The Journal of Infectious Diseases|September 18, 1997
Reciprocal changes in circulating interleukin-6 and its soluble receptor during evolving sepsis in leukocytopenic patientsH Ostermann, K Kratz-Albers, R M Mesters, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 7, 2005
Acquired haemophilia in a patient with gram-negative urosepsis and bladder cancerM Kreuter, S Retzlaff, U Enser-Weis, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Der Internist|December 28, 1999
[Therapy of deep venous thrombosis]R M Mesters
Annals of Hematology|March 4, 2003
Angiogenesis in hematologic malignanciesR M Mesters
Der Internist|September 15, 2000
[Oral anticoagulation versus low-molecular heparin (LMWH)]R M Mesters
Der Internist|January 1, 1995
[Hemorrhagic diathesis]R M Mesters, W Stenzinger
The Journal of Biological Chemistry|December 25, 1991
Identification of a sequence of human activated protein C (residues 390-404) essential for its anticoagulant activityR M Mesters, R A Houghten, J H Griffin
Biochemistry|November 30, 1993
A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor VaR M Mesters, M J Heeb, J H Griffin
Thrombosis and Haemostasis|June 1, 1996
Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsisR M Mesters, N Flörke, H Ostermann, et al.
Protein Science : a Publication of the Protein Society|September 1, 1993
Interactions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein CR M Mesters, M J Heeb, J H Griffin
The Journal of Infectious Diseases|September 18, 1997
Reciprocal changes in circulating interleukin-6 and its soluble receptor during evolving sepsis in leukocytopenic patientsH Ostermann, K Kratz-Albers, R M Mesters, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 7, 2005
Acquired haemophilia in a patient with gram-negative urosepsis and bladder cancerM Kreuter, S Retzlaff, U Enser-Weis, et al.
Pageof 5